BriaCell Therapeutics Corp. (DB: 8BT) has a market capitalization of $30.03M. Last close €3.06 (as of 2026-10-21); 52-week range €2.22 to €11.90. ORTEX data as of 2026-10-19: short interest is 0.77% of free float, 83.1 days to cover and the average cost to borrow is 24.09%.